berberine has been researched along with Ovarian Neoplasms in 11 studies
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study is to analyze the impact of berberine on the two human epithelial ovarian carcinoma cell lines OVCAR-3 and SKOV-3 in relation to the potential usefulness of berberine in the treatment of epithelial ovarian cancer." | 3.78 | Berberine-induced growth inhibition of epithelial ovarian carcinoma cell lines. ( Bae, J; Kim, JB; Lee, SJ; Park, KS, 2012) |
| "Berberine is an effective component extracted from the rhizomes of coptis chinensis and phellodendron chinensis." | 1.62 | Berberine inhibited metastasis through miR-145/MMP16 axis in vitro. ( Jiang, Y; Li, J; Pei, M; Wu, L; Zhang, S, 2021) |
| "Berberine is an extract of a traditional Chinese herbal medicine and has been shown to inhibit the proliferation and induce apoptosis in a wide variety of tumour cells." | 1.42 | Berberine exhibits antitumor effects in human ovarian cancer cells. ( Jin, P; Li, N; Zhang, C, 2015) |
| "Berberine could inhibit miR-21 expression and function in ovarian cancer, as shown by an enhancement of its target PDCD4, an important tumor suppressor in ovarian cancer." | 1.39 | Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis. ( Fang, Y; Li, H; Liu, S; Shen, H; Xu, W, 2013) |
| "Berberine is a natural isoquinoline alkaloid with significant antitumor activity against many types of cancer cells, including ovarian tumors." | 1.39 | Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells. ( Costi, MP; Ferrari, S; Frassineti, C; Ligabue, A; Lombardi, P; Marverti, G; Monti, MG, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, TC | 1 |
| Wu, K | 1 |
| Lin, YY | 1 |
| Kuo, HP | 1 |
| Kao, MC | 1 |
| Wang, V | 1 |
| Hsu, SC | 1 |
| Lee, SL | 1 |
| Li, J | 2 |
| Zhang, S | 1 |
| Wu, L | 1 |
| Pei, M | 1 |
| Jiang, Y | 1 |
| Zhao, Y | 2 |
| Yang, X | 1 |
| Zhao, J | 1 |
| Gao, M | 1 |
| Zhang, M | 1 |
| Shi, T | 1 |
| Zhang, F | 2 |
| Zheng, X | 2 |
| Pan, Y | 2 |
| Shao, D | 2 |
| He, K | 2 |
| Chen, L | 2 |
| Hou, D | 1 |
| Xu, G | 1 |
| Zhang, C | 2 |
| Li, B | 1 |
| Qin, J | 1 |
| Hao, X | 1 |
| Liu, Q | 1 |
| Zhang, X | 1 |
| Liu, J | 2 |
| Wei, J | 1 |
| Gong, Y | 1 |
| Liu, Z | 1 |
| Shao, C | 1 |
| Cui, L | 1 |
| Zhang, H | 1 |
| Liu, L | 1 |
| Fan, J | 1 |
| Ai, G | 1 |
| Luo, N | 1 |
| Li, C | 1 |
| Cheng, Z | 1 |
| Liu, S | 1 |
| Fang, Y | 1 |
| Shen, H | 1 |
| Xu, W | 1 |
| Li, H | 1 |
| Marverti, G | 1 |
| Ligabue, A | 1 |
| Lombardi, P | 1 |
| Ferrari, S | 1 |
| Monti, MG | 1 |
| Frassineti, C | 1 |
| Costi, MP | 1 |
| Jin, P | 1 |
| Li, N | 1 |
| Park, KS | 1 |
| Kim, JB | 1 |
| Lee, SJ | 1 |
| Bae, J | 1 |
| Iwasa, K | 1 |
| Moriyasu, M | 1 |
| Yamori, T | 1 |
| Turuo, T | 1 |
| Lee, DU | 1 |
| Wiegrebe, W | 1 |
11 other studies available for berberine and Ovarian Neoplasms
| Article | Year |
|---|---|
Dual down-regulation of EGFR and ErbB2 by berberine contributes to suppression of migration and invasion of human ovarian cancer cells.
Topics: Berberine; Cell Line, Tumor; Down-Regulation; ErbB Receptors; Female; Humans; Ovarian Neoplasms; Pho | 2021 |
Berberine inhibited metastasis through miR-145/MMP16 axis in vitro.
Topics: Berberine; Cell Line, Tumor; Female; Humans; Matrix Metalloproteinase 16; MicroRNAs; Neoplasm Metast | 2021 |
Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1.
Topics: Antineoplastic Agents; Berberine; Carboplatin; Cell Line, Tumor; Cell Movement; Coculture Techniques | 2021 |
Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibition.
Topics: Apoptosis; Berberine; Cell Line, Tumor; DNA Damage; Female; Humans; Ovarian Neoplasms; Oxidative Str | 2017 |
Berberine inhibits the chemotherapy-induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer.
Topics: Apoptosis; Arachidonic Acid; Berberine; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Prolif | 2017 |
Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Berberine; Caspase | 2019 |
Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis.
Topics: 3' Untranslated Regions; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Berberine; | 2013 |
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells.
Topics: Acetyltransferases; Berberine; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neo | 2013 |
Berberine exhibits antitumor effects in human ovarian cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Berberine; Cell Line, Tumor; | 2015 |
Berberine-induced growth inhibition of epithelial ovarian carcinoma cell lines.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Berberine; Carcinoma, Ovarian Epithelial; Cell Cycle; | 2012 |
In vitro cytotoxicity of the protoberberine-type alkaloids.
Topics: Animals; Antineoplastic Agents, Phytogenic; Berberine; Berberine Alkaloids; Brain Neoplasms; Breast | 2001 |